Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
RareStone Pharmaceuticals
Shanghai, Shanghai, China
- Ownership
- Private
- Development stage
- Other
01
Overview
RareStone is a Shanghai-based rare disease-focused therapeutics company for the Greater China market. It in-licenses and develops rare disease drugs, including pitolisant (Wakix) for narcolepsy, which has been approved by the China NMPA for excessive daytime sleepiness and cataplexy in adult narcolepsy patients, and setmelanotide (Imcivree) for rare genetic obesity disorders under an exclusive Greater China licensing agreement with Rhythm Pharmaceuticals. The company is commercial or near-commercial in China for pitolisant and is pursuing approvals for setmelanotide and other in-licensed endocrine/rare disease products.[1][4][10]
- Therapeutic areas
- EndocrinologyNeurologyPulmonologyRare DiseasesMetabolic Disorders
- Modalities
- Small moleculePeptidesProtein
- Industry
- Biotech
02
Partnerships
Rhythm Pharmaceuticals (exclusive Greater China licensing agreement for setmelanotide/Imcivree)[2][4][6]Bioprojet (collaboration to bring pitolisant/Wakix to China)[1][10]Partners for Alkindi and Efmody (exclusive Greater China rights for CAH and adrenal insufficiency products; partner names not specified in provided sources)[4]
Beyond the preview
Go deeper on RareStone Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on RareStone Pharmaceuticals.